Analyst Ratings for Actuate Therapeutics (ACTU)

ACTU Rating Summary

ACTU Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ACTU
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $17.80 (+2818%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/30/2026 Rodman & Renshaw Michael King Jr. New Coverage Buy
(N/A)		 6.00
(N/A)		 1.08
(0.61)		 -43.52% Details
8/26/2025 B.Riley
» Updated 4/15/2026		 Mayank Mamtani New Coverage Buy
(N/A)		 8.00
(20.00)		 8.36
(0.61)		 -92.7% Details